1. Home
  2. Research
  3. Research Groups
  4. Surgical research in urology and renal trasplantation

Surgical research in urology and renal trasplantation

Search for publications

Only original articles, editorials, guidelines.

  • Ruz-Caracuel I, Caniego-Casas T, Alonso-Gordoa T, Carretero-Barrio I, Ariño-Palao C, Santón A, Rosas M, Pian H, Molina-Cerrillo J, Luengo P, Palacios J.

    Transcriptomic Differences in Medullary Thyroid Carcinoma According to Grade.

    ENDOCRINE PATHOLOGY . 35(3): 207-218. Number of citations: 1

    [doi:10.1007/s12022-024-09817-0]

  • Laszkiewicz J, Krajewski W, Sójka A, Nowak L, Chorbinska J, Subiela JD, Tomczak W, Del Giudice F, Malkiewicz B, Szydelko T.

    Blood-, Tissue- and Urine-Based Prognostic Biomarkers of Upper Tract Urothelial Carcinoma.

    DIAGNOSTICS . 14(17): .

    [doi:10.3390/diagnostics14171927]

  • Albarrán V, Guerrero P, de Quevedo CG, González C, Chamorro J, Rosero DI, Moreno J, Calvo JC, de Aguado PP, Alía V, Sotoca P, Barrill AM, Román MS, Álvarez-Ballesteros P, Serrano JJ, Soria A, Olmedo ME, Saavedra C, Cortés A, Gómez A, Lage Y, Ruiz Á, Ferreiro MR, Longo F, Garrido P, Gajate P.

    Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent.

    CANCER IMMUNOLOGY IMMUNOTHERAPY . 73(10): 186-186. Number of citations: 2

    [doi:10.1007/s00262-024-03772-9]

  • Gómez-Gómez E, Martínez-Salamanca JI, Bianco F, Miles BJ, Burgos J, Quintas JJ, Cano-Castiñeira R, Gómez-Ferrer Á, Rodríguez-Antolín A, Chéchile G, Fernández L, Martín A, Hidalgo P, Parramón M.

    ProsTAV, a clinically useful test in prostate cancer: an extension study.

    WORLD JOURNAL OF UROLOGY . 42(1): 395-395.

    [doi:10.1007/s00345-024-05098-8]

  • Fiala O, Buti S, Bamias A, Massari F, Pichler R, Maruzzo M, Grande E, De Giorgi U, Molina-Cerrillo J, Seront E, Calabrò F, Myint ZW, Facchini G, Kopp RM, Berardi R, Kucharz J, Vitale MG, Pinto A, Formisano L, Büttner T, Messina C, Monteiro FSM, Battelli N, Kanesvaran R, Büchler T, Kopecký J, Santini D, Giudice GC, Porta C, Santoni M.

    Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study).

    TARGETED ONCOLOGY . 19(4): 587-599.

    [doi:10.1007/s11523-024-01065-w]

  • Scilipoti P, Slusarczyk A, de Angelis M, Soria F, Pradere B, Krajewski W, D'Andrea D, Mari A, Giudice FD, Pichler R, Subiela JD, Afferi L, Albisinni S, Mertens L, Laukhtina E, Mori K, Radziszewski P, Shariat SF, Necchi A, Xylinas E, Gontero P, Rouprêt M, Montorsi F, Briganti A, Moschini M.

    The Role of Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.

    European Urology Oncology . 7(6): 1293-1302. Number of citations: 1

    [doi:10.1016/j.euo.2024.06.005]

  • Sáenz-Medina J, Gómez Dos Santos V, Rodríguez-Monsalve M, Muriel-García A, Durán-Poveda M, Gómez Del Val A, Burgos Revilla J, Prieto D.

    Cardiovascular and Cerebrovascular Morbidity in Patients with Urolithiasis: An Epidemiological Approach Based on Hospitalization Burden Data from 1997 to 2021.

    Journal Of Clinical Medicine . 13(12): .

    [doi:10.3390/jcm13123564]

  • Incorvaia L, Monteiro FSM, Massari F, Park SH, Roviello G, Fiala O, Myint ZW, Kucharz J, Molina-Cerrillo J, Santini D, Buttner T, Poprach A, Kopecky J, Zeppellini A, Pichler M, Buchler T, Pichler R, Facchini G, Fay AP, Soares A, Manneh R, Iezzi L, Kuronya Z, Russo A, Bourlon MT, Bhuva D, Ansari J, Kanesvaran R, Grande E, Buti S, Santoni M.

    Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.

    CANCER IMMUNOLOGY IMMUNOTHERAPY . 73(8): 142-142.

    [doi:10.1007/s00262-024-03719-0]

  • Rizzo A, Buti S, Giannatempo P, Salah S, Molina-Cerrillo J, Massari F, Kopp RM, Fiala O, Galli L, Myint ZW, Tural D, Soares A, Pichler R, Mennitto A, Abahssain H, Calabrò F, Monteiro FSM, Albano A, Mollica V, Giudice GC, Takeshita H, Santoni M.

    Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project.

    CLINICAL & EXPERIMENTAL METASTASIS . 41(5): 655-665.

    [doi:10.1007/s10585-024-10296-0]

  • López Valcárcel M, Barrado Los Arcos M, Ferri Molina M, Cienfuegos Belmonte I, Duque Santana V, Gajate Borau P, Fernández Ibiza J, Álvarez Maestro M, Sargos P, López Campos F, Couñago F.

    Is trimodal therapy the current standard for muscle-invasive bladder cancer?

    Actas Urologicas Espanolas . 48(5): 345-355.

    [doi:10.1016/j.acuroe.2024.04.001]

  • Núñez-Gil IJ, Rodríguez-Caulo EA, García-Cosío MD, Piñón M, Díez-Del Hoyo F, Eixerés A, Carrasco-Chinchilla F, López-Menéndez J, Pérez-Villacastín J, Rodríguez-Roda J.

    Cardiovascular surgery and cardiology, current status of two sister specialties in Spain: the CARDIOXCARDIO study.

    Revista espanola de cardiologia (English ed.) . 77(9): 759-766.

    [doi:10.1016/j.rec.2024.05.004]

  • Caño Velasco J, Artero Fullana S, Polanco Pujol L, Lafuente Puentedura A, Subiela JD, Aragón Chamizo J, Moralejo Gárate M, Hernández Fernández C.

    Use of Bladder Epicheck® in the follow-up of high-risk non-muscle-invasive Bladder cancer: A systematic literature review.

    Actas Urologicas Espanolas . 48(8): 555-564.

    [doi:10.1016/j.acuroe.2024.05.004]

  • Carnero-Alcazar, Manuel, Lopez-Menendez, Jose, Cuerpo-Caballero, Gregorio, Hernandez, Tomasa Centella, Polo-Lopez, Luz, Fuster, Rafael Garcia, Monguio, Emilio, Rodriguez-Roda, Jorge.

    Spanish cardiovascular surgery report 2022: The annual updated registry of the Spanish Society for Cardiovascular and Endovascular Surgery

    Cirugia Cardiovascular . 31(3): 114-125.

    [doi:10.1016/j.circv.2024.03.006]

  • Varela-Barca L, López-Menéndez J.

    Perioperative risk stratification scores in infective endocarditis and its usefulness.

    Indian Journal of Thoracic and Cardiovascular Surgery . 40(Suppl 1): 47-60.

    [doi:10.1007/s12055-023-01644-y]

  • Calleja Hermosa P, Sánchez Guerrero C, Viegas V, Rebassa LLul M, Jiménez Cidre M, Morán Pascual E, Errando Smet C, Arlandis Guzmán S, Martínez Cuenca E, Gómez de Vicente JM, Ruiz Hernández M, Casado Varela J, Mora Gurrea J, Pérez Polo M, López-Fando Lavalle L.

    Anatomical outcomes and complications of sacrocolpopexy using Surelift Uplift mesh: A multicentric observational study.

    INTERNATIONAL JOURNAL OF UROLOGY . 31(8): 913-919. Number of citations: 1

    [doi:10.1111/iju.15486]

  • Meagher MF, Minervini A, Mir MC, Cerrato C, Rebez G, Autorino R, Hampton L, Campi R, Kriegmair M, Linares E, Hevia V, Musquera M, D'Anna M, Roussel E, Albersen M, Pavan N, Claps F, Antonelli A, Marchioni M, Paksoy N, Erdem S, Derweesh IH.

    Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy.

    European Urology Open Science . 63: 71-80. Number of citations: 1

    [doi:10.1016/j.euros.2024.02.001]

  • Massari F, Santoni M, Takeshita H, Okada Y, Tapia JC, Basso U, Maruzzo M, Scagliarini S, Büttner T, Fornarini G, Myint ZW, Galli L, Souza VC, Pichler R, De Giorgi U, Gandur N, Lam ET, Gilbert D, Popovic L, Grande E, Mammone G, Berardi R, Crabb SJ, Kemp R, Molina-Cerrillo J, Freitas M, Luz M, Iacovelli R, Calabrò F, Tural D, Atzori F, Küronya Z, Chiari R, Campos S, Caffo O, Fay AP, Kucharz J, Zucali PA, Rinck JA, Zeppellini A, Bastos DA, Aurilio G, Mota A, Trindade K, Ortega C, Sade JP, Rizzo M, Fiala O, Vau N, Giannatempo P, Barillas A, Monteiro FSM, Dauster B, Mennitto A, Nogueira L, de Carvalho Fernandes R, Seront E, Aceituno LG, Grillone F, Cutuli HJ, Fernandez M, Bassanelli M, Kopp RM, Roviello G, Abahssain H, Procopio G, Milella M, Kopecky J, Martignetti A, Messina C, Caitano M, Inman E, Kanesvaran R, Herchhorn D, Santini D, Bamias A, Bisonni R, Mosca A, Morelli F, Maluf F, Soares A, Nunes F, Pinto A, Zgura A, Incorvaia L, Ansari J, Zabalza IO, Landmesser J, Rizzo A, Mollica V, Marchetti A, Rosellini M, Sorgentoni G, Battelli N, Buti S, Porta C, Bellmunt J.

    Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.

    CANCER IMMUNOLOGY IMMUNOTHERAPY . 73(6): 106-106.

    [doi:10.1007/s00262-024-03682-w]

  • Massari F, Mollica V, Fiala O, De Giorgi U, Kucharz J, Vitale MG, Molina-Cerrillo J, Facchini G, Seront E, Lenci E, Bourlon MT, Carrozza F, Pichler R, Lolli C, Myint ZW, Kanesvaran R, Torniai M, Rescigno P, Gomez de Liaño A, Zakopoulou R, Buti S, Porta C, Grande E, Santoni M.

    Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study.

    European Urology Oncology . 7(5): 1123-1131. Number of citations: 1

    [doi:10.1016/j.euo.2024.03.011]